Showing results (851-860 of 2,903) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|November 27, 2021
Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefitDean C Singleton, Alexandra M Mowday, Chris P Guise, et al.Cancer Gene Therapy|March 23, 2021
Engineered cells as glioblastoma therapeuticsAparna Ramanathan, Ian A J LorimerCancer Gene Therapy|January 13, 2022
Protooncogene MYC drives human melanocyte melanogenesis and senescenceLucía San Juan, María Luisa Cagigal, Angel Fernandez-Flores, et al.Cancer Gene Therapy|January 13, 2022
Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapyFan Kou, Lei Wu, Ye Zhu, et al.Cancer Gene Therapy|January 13, 2022
Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemiaPaniz Tavakoli Shirazi, Laura N Eadie, Susan L Heatley, et al.Cancer Gene Therapy|November 25, 2018
Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphomaQing-Ming Wang, Guang-Yu Lian, Yuan Song, et al.Cancer Gene Therapy|January 27, 2021
Circular RNA FLNA acts as a sponge of miR-486-3p in promoting lung cancer progression via regulating XRCC1 and CYP1A1Jiongwei Pan, Gang Huang, Zhangyong Yin, et al.Cancer Gene Therapy|April 1, 2017
Her-2 expression regulated by downregulation of miR-9 and which affects chemotherapeutic effect in breast cancerG Sun, L Sun, Y Liu, et al.Cancer Gene Therapy|February 11, 2017
Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transitionH Yin, X Huang, M Tao, et al.Cancer Gene Therapy|November 8, 2021
Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of originDai Shimizu, Kenzui Taniue, Yusuke Matsui, et al.Pageof 291